Protocolo Péptidos Request protocol →ES · EN
Research reference · 10 mg vial

Epithalon dosage & reconstitution (10 mg vial)

Epithalon dosage: calculations for a 10 mg vial use the same amounts described in the literature. Adding 2 mL of bacteriostatic water produces 5 mg/mL, so each U-100 unit contains 50 mcg.

Vial strength 10mg 50mg
01

Epithalon Quick Reference (10 mg vial)

Vial contents10 mg Epithalon
Final volume2 mL
Concentration5 mg/mL
One U-100 unit50 mcg in 0.01 mL
Epithalon 10mg

Research context: mechanisms, human and preclinical evidence, limitations and precautions are in How this works and References. The calculator (Spanish) converts any other volume.

02

Epithalon Dosage Chart (10 mg vial)

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard Protocol (2 mL = ~5 mg/mL)

Week / phaseDaily doseUnits per injection (mL)
Days 1–20 (Cycle On)5 mg (5000 mcg)100 units (1.00 mL)
Weeks 4–26 (Cycle Off)0 mcg0 units (0.00 mL)

Frequency: Once daily, subcutaneously, at a consistent time.

Reconstitution Steps

  1. Draw 2 mL of bacteriostatic water with a sterile syringe.1
  2. Inject slowly down the vial wall; avoid shaking to prevent foaming.2
  3. Gently swirl or roll until fully dissolved (clear solution).3
  4. Label with the reconstitution date and refrigerate at 2–8 °C, protected from light; use within 4 weeks.4

The per-phase amounts are identical across the Epithalon family. The 10 mg vial only changes the concentration, U-100 units, volume and supplies.

Important: this guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

U-100 Conversion Table (2 mL = 5 mg/mL)

U-100 unitsVolumeContainsYield per vial
20.02 mL100 mcg100 injections
50.05 mL250 mcg40 injections
100.10 mL500 mcg20 injections
200.20 mL1 mg (1000 mcg)10 injections
300.30 mL1.5 mg (1500 mcg)6 injections
500.50 mL2.5 mg (2500 mcg)4 injections
1001.00 mL5 mg (5000 mcg)2 injections
03

Supplies Needed

Straightforward 12- and 24-week planning for a 10 mg vial at 5 mg/mL.

Epithalon vials (10 mg each)

  • Standard Protocol, 12 weeks: Minimum 11 vials (105 mg required).
  • Standard Protocol, 24 weeks: Minimum 11 vials (105 mg required).

U-100 syringes (1 mL)

  • Standard Protocol, 12 weeks: 84 new syringes for 84 injections.
  • Standard Protocol, 24 weeks: 168 new syringes for 168 injections.

Bacteriostatic water

  • Standard Protocol, 12 weeks: 22 mL total (2 mL per vial) → 8 × 3 mL vials.
  • Standard Protocol, 24 weeks: 22 mL total (2 mL per vial) → 8 × 3 mL vials.

Alcohol swabs

  • Standard Protocol, 12 weeks: 168 minimum; one box of 100 does not cover the calculation.
  • Standard Protocol, 24 weeks: 336 minimum; one box of 100 does not cover the calculation.

Sharps container: one appropriately sized. Stability planning: totals are minimum arithmetic quantities; follow the product documentation for sterility, storage, handling loss and discard timing.

Epithalon 10mgView in store
U-100 syringes (1 mL)1 mL, fine needle
Bacteriostatic water 3 mLView in store
Alcohol swabs70 % isopropyl

Store links may earn a commission. A supplier page is not scientific evidence or proof of suitability for human use.

04

Epithalon Vial and Research Context

  • Reconstitute: add 2 mL of bacteriostatic water to produce 5 mg/mL.
  • Frequency in the source: once daily, subcutaneously.
  • Described range: schedules run from 5 mg (5000 mcg) to 5 mg (5000 mcg) per injection.
  • Easy measuring: 1 U-100 unit = 0.01 mL = 50 mcg.
  • Vial size: the 10 mg label is total nominal content, not a per-injection amount.
  • Vial coverage: at 5 mg (5000 mcg) per injection one vial supplies 2 injections; at 5 mg (5000 mcg) it supplies 2. These are mass calculations, not storage periods.
05

Protocol Overview

Quick reference for the schedules shared by the cited literature.

  • Frequency: once daily.
  • Concentration: 10 mg in 2 mL = 5 mg/mL.
  • Unit conversion: 1 U-100 unit = 50 mcg.
06

Dosing Schedule

The tables keep each approach separate.

  • Standard Protocol: 5 mg (5000 mcg), in phases (once daily).
  • Measurement: use the units and mL shown beside each amount.
  • Consistency: vial size does not change the schedule.
07

Storage Instructions

  • Lyophilized (unopened): −20 °C for long-term storage; 2–8 °C if used within weeks. Protected from light.
  • Reconstituted: 2–8 °C, do not freeze. Use within the documented period (typically up to 4 weeks with bacteriostatic water).
  • Handling: do not shake; avoid temperature cycling; label with date and concentration.
  • Discard: cloudy solutions, particulates or expired preparations are discarded.

More detail in the storage guide (Spanish).

08

Important Notes

  • Research only: the referenced compounds are sold for laboratory research. Nothing here is medical advice or an administration schedule.
  • Above 100 units: a 1 mL U-100 syringe cannot hold them; split across syringes or reconstitute with less volume.
  • Accuracy: concentration depends on the actual volume added; measure the diluent with a syringe, not by eye.
  • Verification: confirm vial contents against the batch certificate of analysis before calculating.
09

How This Works

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide of sequence Ala-Glu-Asp-Gly (AEDG), presented as a 10 mg lyophilized research vial.

Signaling pathways documented in the literature:

  • Telomerase activation (hTERT): Cellular models document induction of telomerase activity and telomere elongation in cultured human fibroblasts
  • Circadian modulation: Preclinical rodent studies describe normalization of melatonin secretion and circadian rhythm
  • Gene Regulation / Chromatin Experimental literature reports effects on gene expression and chromatin structure (perinuclear heterochromatin).
10

Research Applications

  • Khavinson VK et al., Neuro Endocrinol Lett 2003 (PMID 14523363): Epithalon in models of cellular aging and telomerase activation
  • Anisimov VN et al., Mech Ageing Dev 2003 (PMID 12782392): Epithalon in murine models of longevity and carcinogenesis
  • Khavinson VK, Bull Exp Biol Med 2002 (PMID 12937682): Effects of the tetrapeptide on telomerase activity in human cell cultures

Research material only. No FDA-approved human use. All information is provided for educational and scientific literature reference purposes.

11

Injection Technique in Research

  • Route in the studies: subcutaneous, in abdominal or thigh adipose tissue, rotating the site.
  • Syringe: 1 mL U-100 (100 units); read in units, not mL.
  • Asepsis: alcohol swab on the stopper and the site; a new syringe per injection.
  • Drawing: purge air, draw the units from the chart and verify before withdrawing the needle from the vial.

Full guide: U-100 syringes and reading units (Spanish).

12

Research Note

All content on this page is technical and educational. It describes how a vial is reconstituted, how a syringe is read and which amounts the cited sources describe. It does not replace the supervision of a qualified researcher or the judgment of a health professional, and it is not intended to diagnose, treat, cure or prevent any disease.

13

Related Protocols

Research material only. Technical and educational content. Not medical advice, an administration schedule or a recommendation for use, and not intended to diagnose, treat, cure or prevent any disease. The referenced compounds are sold for laboratory research.

This site is an independent publication. Supplier links may earn a commission.